Yoshikawa Takaki, Hayashi Tsutomu, Nishino Masashi, Ogawa Rei, Fujisaki Yurina, Wada Takeyuki, Yamagata Yukinori, Seto Yasuyuki
Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan.
Asian J Endosc Surg. 2025 Jan-Dec;18(1):e70012. doi: 10.1111/ases.70012.
Robotic surgery may have shown advantages over conventional laparoscopic surgery, but the da Vinci SP system, which utilizes a single incision, has had limited use in gastric cancer surgery. This study aims to evaluate the short-term outcomes of a novel hybrid technique, minimally invasive laparoscopic and robotic surgery (MILAR), with the da Vinci SP system for gastric cancer.
This retrospective study reviewed 23 consecutive patients who underwent gastrectomy for gastric cancer using the MILAR technique with the da Vinci SP system between May and October 2024. Operative time, blood loss, and morbidity were analyzed.
The median operation time was 192 min (191 min for distal gastrectomy, 174 min for proximal gastrectomy, and 308 min for total gastrectomy). Blood loss was minimal, with a median of 13 mL and no patient exceeding 250 mL. Postoperative complications were also minimal; one patient developed a grade II intra-abdominal fluid infection and another had grade II enteritis. There were no anastomotic leakages or pancreatic fistulas, and no grade III or higher complications were observed.
MILAR using the da Vinci SP system is feasible and safe for gastric cancer surgery, with minimal blood loss and acceptable operative times. This is the first report from Japan showing the successful application of this system in gastric cancer, offering new prospects in minimally invasive surgery.
机器人手术可能已显示出优于传统腹腔镜手术的优势,但采用单切口的达芬奇SP系统在胃癌手术中的应用有限。本研究旨在评估一种新型混合技术——微创腹腔镜与机器人手术(MILAR)联合达芬奇SP系统用于胃癌手术的短期疗效。
这项回顾性研究纳入了2024年5月至10月期间连续23例行胃癌根治术并采用MILAR技术联合达芬奇SP系统的患者。分析手术时间、失血量和发病率。
中位手术时间为192分钟(远端胃癌根治术为191分钟,近端胃癌根治术为174分钟,全胃癌根治术为308分钟)。失血量极少,中位失血量为13毫升,无患者失血量超过250毫升。术后并发症也极少;1例患者发生Ⅱ级腹腔内积液感染,另1例发生Ⅱ级肠炎。无吻合口漏或胰瘘,未观察到Ⅲ级或更高等级的并发症。
使用达芬奇SP系统的MILAR技术用于胃癌手术是可行且安全的,失血量极少,手术时间可接受。这是日本首份展示该系统在胃癌手术中成功应用的报告,为微创手术提供了新的前景。